Results 181 to 190 of about 3,048,170 (258)

The Evolving Biliary Multi-Omics Framework in Gallbladder Cancer: A Reply to Critiques on Confounders, Viability, and Host Defenses. [PDF]

J Gastroenterol Hepatol
Das D, Dixit R, Pandey M.
europepmc   +1 more source

Erratum: [Corrigendum] Effects of Platycodin D on apoptosis, migration, invasion and cell cycle arrest of gallbladder cancer cells. [PDF]

Oncol Lett
Zhang X, Zhai T, Hei Z, Zhou D, Jin L, Han C, Wang J.   +6 more
europepmc   +1 more source

Development of a Prognostic Survival Risk Score for Lung Cancer Patients With Type 2 Diabetes Mellitus: A Territory‐Wide Retrospective Cohort Study

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Lung cancer is a leading cause of cancer‐related mortality, and its prognosis is often affected by comorbidities such as type 2 diabetes mellitus (T2DM). This study aimed to identify survival risk factors for lung cancer patients with T2DM, evaluate the predictive models, and develop a risk score system for survival prediction ...
Claire Chenwen Zhong, Junjie Huang, Zhaojun Li, Yu Jiang, Zehuan Yang, Jinqiu Yuan, Xiaodan Huang, Xiaofang Liu, Han Wang, Jonathan Poon, Qi Dou, Arthur Sung, Martin C. S. Wong   +12 more
wiley   +1 more source

Comparative analysis of genomic profiles and clinical outcomes in cholangiocarcinoma and gallbladder cancer. [PDF]

Sci Rep
Lu W, Liu R, Liu C, Pang J, Yin J, Zhang Z.   +5 more
europepmc   +1 more source

Association of Vitamin D Status With Total and Site‐Specific Cancer Mortality From Tropical to Subantarctic Latitudes: A Nationwide Population‐Based Study in Chile

Cancer Medicine, Volume 15, Issue 9, September 2026.
In this nationwide ecological study, population‐based vitamin D levels were inversely associated with age‐standardized mortality rates for multiple cancers across Chile, with strongest associations observed for endometrial, thyroid and colorectal cancer.
Gonzalo Muñoz, Juan Pablo Fraga, Ignacia S. Núñez‐Ulloa, Alvaro Passi‐Solar, Bruno Nervi, Sebastián Mondaca, Paula Margozzini, Carlos A. Camargo Jr., Arturo Borzutzky   +8 more
wiley   +1 more source

Synchronous Duodenal and Pancreatic Metastases From Clear Cell Renal Cell Carcinoma 18 Years After Nephrectomy: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT A 63‐year‐old man presented with melena and severe anemia 18 years after nephrectomy for clear cell renal cell carcinoma. Imaging and biopsy confirmed duodenal and pancreatic metastases mimicking pancreaticobiliary malignancy. He underwent pancreaticoduodenectomy.
Ankit Kulkarni, Suhail Sapkota, Sai Sushrutha Mudupula Vemula, Shreya Motkur, Adarsh Jha, Rutwik Pradeep Sharma, Sumugdha Rayamajhi   +6 more
wiley   +1 more source

Erratum: [Corrigendum] MicroRNA-182 promotes epithelial-mesenchymal transition by targeting FOXN3 in gallbladder cancer. [PDF]

Oncol Lett
Zhang J, Hu Z, Wen C, Liao Q, He B, Peng J, Tang X, Chen Z, Xie Y.   +8 more
europepmc   +1 more source

Artificial Intelligence Resources for the Screening of Titles and Abstracts in Systematic Reviews: A Scoping Review

Cochrane Evidence Synthesis and Methods, Volume 4, Issue 5, September 2026.
ABSTRACT Introduction Artificial intelligence (AI) is a branch of technology enabling machines to emulate complex human skills; it can also entail problem‐solving using bioinspired methods. It is used for automating systematic literature reviews (SLR), that is, defining a clinical question, locating relevant literature, preliminary screening, study ...
Ana M. Barragán, Sara Elena Ortiz Bonett, Eliana‐Isabel Rodríguez‐Grande, Alvaro David Orjuela‐Cañón, Oscar J. Perdomo, Guillermo Sánchez‐Vanegas   +5 more
wiley   +1 more source

Temporal trends in the incidence and prognosis of lung metastasis in gallbladder cancer: risk stratification and survival analysis. [PDF]

Am J Cancer Res
Yu Y, Li X, Hui JJ, Li D.
europepmc   +1 more source

Cancer‐related pain: A bidirectional modulator of cancer progression

Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
CRP and tumour progression engage in a dynamic, bidirectional circuit mediated by multiple mechanisms involving neuroimmunology and cancer ‐neuroscience. Analgesic interventions may affect tumour progression, while anticancer therapies can influence pain. Targeting pain in cancer may have promising therapeutic value in cancer progression.
Junzhe He, Yu Zhang, Qian Liu, Biao Yan, Peiwei Chai, Renbing Jia   +5 more
wiley   +1 more source